VC  BioVentures Investors

     Office Locations:

70 Walnut Street, Suite 302
Wellesley, MA 02481
Phone: 617-252-3443
Fax: 617-621-7993



  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    The BioVentures Investors Group provides early-stage venture capital financing to enterprises in the healthcare industry. The firm's investments are concentrated in four areas: drug development, genomics, medical devices, and medical software. The three General Partners of the firm have all been CEOs of companies active in the biotech industry and have 62 years of combined experience. BioVentures currently manages three funds with over $133 million under management. Investments in individual companies typically range from $3 to $10 million dollars, with the expectation that a monetizing opportunity will be reached in less than five years with a total capital requirement of $15 million to $20 million. Although the firm focuses primarily on businesses that have a management team in place and have data from initial research and development to support claims, it will consider seed-stage investments.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Jeffrey Barnes MS, MBA General Partner
    Marc Goldberg JD, MBA General Partner
    Peter Feinstein General Partner
    Walter Gilbert PhD General Partner


    Recent Funding Events (trailing 12 months):










      Series D


    Portfolio companies include:

        web link

        web link

      Deep Vein Medical

        web link

        web link

      Locemia Solutions
        web link

      POC Medical Systems
        web link

        web link

      Verax Biomedical
        web link


    Recent News: